The Power of the Site Initiation Visit (SIV) in Africa And Why eMQT Does It Differently
A Site Initiation Visit (SIV) is often described as the formal beginning of a clinical study. At its core is a comprehensive review of the protocol, the bible of every study, if you will. It also involves delegation of roles and responsibilities to the site team, verifying study logistics, ensuring that all ethics and regulatory approvals are in place, and confirming that the Investigator Site File (ISF) contains all the required essential records to support the study.
More often than not, it’s also the first time all the study stakeholders i.e. sponsors, site teams, investigators, coordinators, monitors etc. come together to clarify expectations and lay the foundation for successful delivery of the study. It is, in every meaningful sense, study day one: the moment after which the real work of the study begins.
On paper, these objectives of an SIV are a familiar and straightforward checklist for every site in every region. However, standard checklists assume trust already exists, and for many global sponsors, Africa is still viewed through a lens of uncertainty. So, while every site across the world must prove study readiness, African sites are often asked to prove something more delicate: confidence in systems that have historically been considered unstable.
This is why at eMQT, we move beyond this standard checklist and translate the basic protocol presentation into a step-by-step visual journey, a detailed video tool that allows site teams to see, hear and feel what successful delivery looks like. From patient flow to data capture, from lab processes to compliance requirements, nothing is left abstract. In some cases, we go even further by acting out each stage of site workflow so that procedures are understood not just intellectually, but practically.
In addition to protocol training, all site staff also receive Good Clinical Practice (GCP) training led by our Chief Operating Officer, Dr Tina Barton. As a Board Member and Trainer of the Institute of Clinical Research, this ensures that our study teams are trained to the high international standards expected across global clinical research.
This SIV experience is not created overnight, it can take up to two months of dedicated development and precision in every detail to replace abstraction with clarity. This results in an intentional, interactive, and immersive process where teams ask better questions, investigators engage more confidently, and the entire site team develops a sense of ownership in the role they are being asked to play.
For African sites, we understand that clarity drives confidence, and confidence drives performance. With each SIV, we are helping reshape what global clinical research looks like on this important, yet underused, continent.
At eMQT we do not simply assume readiness, we build it, demonstrate it, and deliver it.
